Ledger.Open graph →
SEC Form D · filed November 8, 2023

Apnimed, Inc

Offering
$37.5M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Francois C. Beaubien · Cambridge, MADirectorJoseph C. Avellone · Cambridge, MADirectorLawrence G. Miller · Cambridge, MAExec · DirectorMichael G. Rogers · Cambridge, MAExecBarry G. Wohl · Cambridge, MAExecIsaac C. Cheng · Cambridge, MADirectorDennis C. Molnar · Cambridge, MAExec · DirectorChris C. Dimitropoulos · Cambridge, MADirectorEvan Sugden · Salt Lake City, UTExec · DirectorWen-Hui Chen · Camana Bay, Cayman IslandsExecRichard H. Coles · Camana Bay, Cayman IslandsExecChristopher O. Day · Camana Bay, Cayman IslandsDirectorTerence S. Greene · New York, NYDirectorPaul C. Fonteyne · Cambridge, MADirectorDavid Eaglesham · Natick, MADirectorPeter Gajdos · Natick, MAExec · DirectorRich Hossfeld · Natick, MADirectorGabriel Kra · Natick, MAExecMark Hutchinson · Natick, MAExecTexo Energy, LLC · Dallas, TXDirectorDerek Warnick · Natick, MAExec · DirectorNatalie Mortimer · Salt Lake City, UTDirectorErin Whitelock · Salt Lake City, UTExec · DirectorFrancois C. Beaubien · Cambridge, MADirectorPaul C. Fonteyne · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗